Transgene: Corporate Overview (Transgene) - Dec 6, 2014 - Anticipated composition of matter patent and use claims patent expiries in 2016, 2017 and 2023; Anticipated expiry of patents covering biomarkers between 2029 and 2030; Anticipated expiry of manufacturing patent in 2027
Anticipated patent expiry • Non Small Cell Lung Cancer
|